SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-079823
Filing Date
2023-07-11
Accepted
2023-07-11 08:16:49
Documents
12
Period of Report
2023-07-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320969d1_8k.htm   iXBRL 8-K 24287
  Complete submission text file 0001104659-23-079823.txt   197028

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inva-20230710.xsd EX-101.SCH 3003
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20230710_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20230710_pre.xml EX-101.PRE 22351
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2320969d1_8k_htm.xml XML 3314
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 231081239
SIC: 2834 Pharmaceutical Preparations